CN115154556A - A Chinese medicinal composition with anti-hangover effect, and its preparation method - Google Patents
A Chinese medicinal composition with anti-hangover effect, and its preparation method Download PDFInfo
- Publication number
- CN115154556A CN115154556A CN202210865332.0A CN202210865332A CN115154556A CN 115154556 A CN115154556 A CN 115154556A CN 202210865332 A CN202210865332 A CN 202210865332A CN 115154556 A CN115154556 A CN 115154556A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- mixed powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 206010019133 Hangover Diseases 0.000 title claims description 13
- 239000003814 drug Substances 0.000 claims abstract description 51
- 239000002994 raw material Substances 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000011812 mixed powder Substances 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 14
- 239000002552 dosage form Substances 0.000 claims abstract description 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 10
- 239000008187 granular material Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000007873 sieving Methods 0.000 claims abstract description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 5
- 239000000600 sorbitol Substances 0.000 claims abstract description 5
- 238000005303 weighing Methods 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 238000005550 wet granulation Methods 0.000 claims abstract description 4
- 241000723353 Chrysanthemum Species 0.000 claims description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 12
- 240000000249 Morus alba Species 0.000 claims description 12
- 235000008708 Morus alba Nutrition 0.000 claims description 12
- 235000014676 Phragmites communis Nutrition 0.000 claims description 12
- 244000046146 Pueraria lobata Species 0.000 claims description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 12
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 11
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 11
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 11
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 10
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 10
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 10
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 10
- 241000234435 Lilium Species 0.000 claims description 10
- 240000003915 Lophatherum gracile Species 0.000 claims description 10
- 241000756042 Polygonatum Species 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000002075 anti-alcohol Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 244000111489 Gardenia augusta Species 0.000 claims 4
- 239000000654 additive Substances 0.000 claims 2
- 235000010356 sorbitol Nutrition 0.000 claims 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- 235000016623 Fragaria vesca Nutrition 0.000 claims 1
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 229940057948 magnesium stearate Drugs 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 229940032147 starch Drugs 0.000 claims 1
- 229940013618 stevioside Drugs 0.000 claims 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims 1
- 235000019202 steviosides Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 14
- 208000007848 Alcoholism Diseases 0.000 abstract description 11
- 201000007930 alcohol dependence Diseases 0.000 abstract description 11
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000035622 drinking Effects 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 16
- 235000019441 ethanol Nutrition 0.000 description 14
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 13
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 13
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 11
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 9
- 241000157835 Gardenia Species 0.000 description 7
- 206010067125 Liver injury Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 231100000753 hepatic injury Toxicity 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241001633680 Polygonatum odoratum Species 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000020927 12-h fasting Nutrition 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000745390 Lophatherum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000020828 fasting Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition with a function of relieving alcoholism, which comprises the following components in part by weight: the invention also provides a preparation method of the traditional Chinese medicine composition with the function of dispelling the effects of alcohol, which comprises the following steps: weighing a certain proportion of the traditional Chinese medicine composition, and crushing and sieving the traditional Chinese medicine composition; uniformly mixing the sieved raw materials with sorbitol to obtain raw material mixed powder; carrying out wet granulation on the raw material mixed powder by using alcohol and drying; mixing the dried granules with magnesium stearate, and uniformly stirring to obtain target mixed powder; and carrying out dosage form treatment on the target mixture to obtain the traditional Chinese medicine composition of the target dosage form. All the substances in the traditional Chinese medicine composition are medicinal and edible substances, and the medicinal and edible substances are used together to eliminate the pungent and hot toxicity of the wine, relieve the physical burden of drinkers, achieve the purposes of refreshing, protecting the liver and the stomach and protect the health of the drinkers.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition with a function of relieving alcoholism and a preparation method thereof.
Background
In daily life, alcohol is indispensable, but drinking alcohol hurts the body, and in severe cases, alcoholism can be caused, so that dysfunction of the human body is caused, and nerves and liver are damaged.
A plurality of anti-alcoholism prescriptions are still in flow from old times to present, a plurality of researches are also carried out on the anti-alcoholism medicines at present, and the researches and the developments of health care products related to the anti-alcoholism are relatively less. The action mechanism of the anti-alcoholism functional health-care product is mainly related to the improvement of the enzyme activity of degrading ethanol in the liver. The existing product for relieving alcoholism, protecting liver and protecting stomach has poor single use effect, and some compound compatibility contains medicines which can not be used for a long time or other raw materials with toxic and side effects, and has the defects of high cost, slow effect, inconvenient use and the like. Therefore, the development of a product which can reduce the uncomfortable drinking feeling, protect the gastric mucosa, reduce the liver injury and improve the sobering-up speed and has high safety has important significance.
Disclosure of Invention
The invention provides a traditional Chinese medicine composition which can reduce the uncomfortable drinking feeling, protect gastric mucosa, reduce liver injury, improve the sobering-up speed and has high safety, and the traditional Chinese medicine composition is realized by the following technical scheme: a traditional Chinese medicine composition with an anti-alcohol function, which comprises: kudzu root, reed rhizome, mulberry leaf, chrysanthemum, lophatherum gracile, lily, polygonatum odoratum, chinese yam, raw gardenia and mint.
The traditional Chinese medicine composition provided by the invention has the following advantages: in the traditional Chinese medicine composition, the kudzu root is sweet and cool and can move and relieve alcoholism, the reed rhizome is sweet and cold and can clear heat and promote fluid production, and the kudzu root and the reed rhizome are monarch drugs. The mulberry leaf and the chrysanthemum enter liver meridian together, and can dispel wind and heat, calm liver and improve vision; lophatherum, herba Lophatheri is sweet and cold, and good at clearing away heart-fire and dysphoria with smothery sensation; yam, yu Zhu and Bai He are sweet and mild in nature and cold, so they are good at nourishing stomach and heart. The six medicines are used as ministerial medicines for clearing heat and nourishing viscera. Raw gardenia is bitter and cold, has the functions of clearing heat and purging fire, cooling blood and detoxifying, and is used as an adjuvant to prevent over-alcohol property and insufficient strength of monarch and minister drugs. Mint is pungent and cool and good at moving through, so it can help mulberry leaf and chrysanthemum to go upward quickly. All the substances in the traditional Chinese medicine composition are medicinal and edible substances, and the medicinal and edible substances are used together to eliminate the toxic heat of the alcohol, relieve the physical burden of drinkers, achieve the purposes of refreshing, protecting the liver and the stomach and protect the health of drinkers.
The invention also provides a preparation method of the traditional Chinese medicine composition with the function of relieving alcoholism, which comprises the following steps:
step one, weighing a certain proportion of kudzu root, reed rhizome, mulberry leaf, chrysanthemum, lophatherum gracile, lily, polygonatum, chinese yam, raw gardenia and mint, and crushing and sieving;
step two, uniformly mixing the sieved raw materials with sorbitol to obtain raw material mixed powder;
step three, carrying out wet granulation on the raw material mixed powder by using alcohol and carrying out drying treatment;
step four, mixing the dried granules with magnesium stearate and uniformly stirring to obtain target mixed powder;
and step five, carrying out dosage form treatment on the target mixed powder to obtain the traditional Chinese medicine composition of the target dosage form.
The dosage form of the traditional Chinese medicine composition is one of tablet candy, tablet, hard capsule, soft capsule, granule, paste, tincture and oral liquid.
The preparation method of the traditional Chinese medicine composition with the hangover alleviating function, provided by the invention, can be used for quickly preparing the traditional Chinese medicine composition with the hangover alleviating function according to the requirements of dosage forms, is simple and efficient, and is suitable for batch production and application of the traditional Chinese medicine composition.
Drawings
FIG. 1 is a graph showing the results of measurement of ADH and ALDH enzyme activities and ALT and AST enzyme activities (n = 5) of the liver of a mouse subjected to an experiment using the composition obtained in the first example of the present invention as an experimental sample.
Detailed Description
The present invention will be described in further detail with reference to specific examples.
Example 1:
a traditional Chinese medicine composition with an anti-alcohol function is prepared from the following raw materials in parts by weight: 10 parts of kudzu root, 10 parts of reed rhizome, 5 parts of mulberry leaf, 5 parts of chrysanthemum, 5 parts of lophatherum gracile, 10 parts of lily, 10 parts of polygonatum, 15 parts of Chinese yam, 5 parts of raw gardenia and 5 parts of mint.
The preparation method of the traditional Chinese medicine composition comprises the following steps:
step one, weighing a certain proportion of kudzu root, reed rhizome, mulberry leaf, chrysanthemum, lophatherum gracile, lily, polygonatum, chinese yam, raw gardenia and mint according to a weight ratio, and crushing and sieving;
weighing raw materials in a certain proportion, crushing and sieving the raw materials, adding a solvent with the volume of 8-10 times of that of the raw materials, extracting, concentrating under reduced pressure, drying, crushing for the second time, and sieving.
The solvent is one of water, ethanol or a mixture of water and ethanol, and preferably water.
Step two, uniformly mixing the sieved raw materials with sorbitol to obtain raw material mixed powder;
step three, carrying out wet granulation on the raw material mixed powder by using alcohol and carrying out drying treatment;
wherein the temperature of the medium drying is preferably 60 ℃, the drying time is preferably 60min, and the moisture content in the dried particles is below 5%.
Step four, mixing the dried granules with magnesium stearate and uniformly stirring to obtain target mixed powder;
and step five, carrying out dosage form treatment on the target mixed powder to obtain the traditional Chinese medicine composition of the target dosage form.
The dosage form of the traditional Chinese medicine composition is one of tablet candy, tablet, hard capsule, soft capsule, granule, paste, tincture and oral liquid.
If the dosage form of the traditional Chinese medicine composition is the tablet candy, the tablet can be processed, so that the tablet candy can be prepared quickly in batch.
Example 2:
a traditional Chinese medicine composition with an anti-alcohol function is prepared from the following raw materials in parts by weight: 20 parts of kudzuvine root, 20 parts of reed rhizome, 8 parts of mulberry leaf, 10 parts of chrysanthemum, 8 parts of lophatherum gracile, 8 parts of lily, 20 parts of fragrant solomonseal rhizome, 25 parts of Chinese yam, 10 parts of raw gardenia and 10 parts of mint.
The preparation method of the traditional Chinese medicine composition is the same as that of example 1, wherein the drying temperature, the drying time and the selected solvent are the same as those of example 1.
Example 3:
a traditional Chinese medicine composition with an anti-alcohol function is prepared from the following raw materials in parts by weight: 30 parts of kudzuvine root, 30 parts of reed rhizome, 10 parts of mulberry leaf, 15 parts of chrysanthemum, 10 parts of lophatherum gracile, 30 parts of lily, 30 parts of fragrant solomonseal rhizome, 40 parts of Chinese yam, 15 parts of raw gardenia and 15 parts of mint.
The preparation method of the traditional Chinese medicine composition is the same as that of example 1, wherein the drying temperature, the drying time and the selected solvent are the same as those of example 1.
The preparation method in the embodiment can quickly prepare the traditional Chinese medicine composition with the function of relieving alcoholism according to the requirement of the dosage form, is simple and efficient, and is suitable for batch production and application of the traditional Chinese medicine composition.
The traditional Chinese medicine composition prepared by the embodiment can reduce the uncomfortable drinking feeling, protect gastric mucosa, reduce liver injury, improve the sobering-up speed and has high safety.
Animal experiments are carried out by taking the composition obtained in the example 1 as an experimental sample, and the hangover alleviating effect and the protective effect on alcoholic liver injury of the composition after drinking are verified.
1 materials of the experiment
1.1 Experimental animals
C57BL/6 mice, SPF grade, 21-24g, purchased from Zhuhai Baidiantong Biotech, inc.
1.2 drugs and reagents
Haiwang Jinzun tablets, the composition prepared in example 1, glutamic-oxaloacetic transaminase (AST) and glutamic-pyruvic transaminase (ALT) determination kit (Nanjing institute of bioengineering Co., ltd.), and tissue Alcohol Dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) determination kit (Nanjing institute of bioengineering Co., ltd.).
1.3 instruments
Electronic balance, constant temperature metal bath, low temperature centrifuge.
2 method of experiment
2.1 determination of alcohol consumption
9 mice were randomly assigned, 3 per group. After fasting for 12 hours, the mice with 56-degree red star Erguotou gavage are respectively given three doses of 0.2ml/20g, 0.3ml/20g and 0.4ml/20g of body weight and are respectively marked as a small-drinking group, a medium-drinking group and a large-drinking group.
After the stomach is filled, the drunkenness state of the mouse is observed, drunkenness is judged according to disappearance of righting reflex, and drunkenness and sobering time and death number of the mouse in 24 hours are recorded.
Calculating the drunkenness rate and the death rate according to the following formula:
table 1 mouse alcohol dosage assay results (n = 3)
| Group of | Gavage amount/20 g | Drunk rate (%) | Mortality (%) |
| Small drinking set | 0.2ml | 33％ | 0％ |
| Middle-volume drinking set | 0.3ml | 100％ | 0％ |
| Bulk drinking set | 0.4ml | 100％ | 100％ |
As can be seen from Table 1, the small-drinking group did not die but the intoxication rate was low (33%), the large-drinking group all died, the medium-drinking group all drunk and did not die within 24h, and the stomach-feeding amount of the medium-drinking group of 0.3ml/20g was supposed to be the drinking dose in the subsequent experiments.
2.2 determination of antialcoholism and hepatoprotective action of drugs
Blank control group: when the drug is administrated, distilled water is given, and the stomach of the mouse is irrigated according to the weight of 0.3ml/20 g; after 30min, the mice were gavaged with distilled water at a volume of 0.3ml/20 g.
Model control group: when the drug is administrated, distilled water is given, and the stomach of the mouse is irrigated according to the weight of 0.3ml/20 g; after 30min, the mice are administrated to 56-degree Hongxing Erguotou intragastric mice according to the drinking dose measurement of the mice and the weight of 0.3ml/20 g.
Positive control group: pulverizing Haiwang Jinzun tablets, dissolving and diluting to 83.3mg/ml liquid medicine according to the weight and the mouse administration conversion coefficient of 9.1, and gavage the mouse according to 0.3ml/20g of the weight; after 30min, the mice are administrated to 56-degree Hongxing Erguotou intragastric mice according to the drinking dose measurement of the mice and the weight of 0.3ml/20 g.
Administration group: according to the calculation of the body weight and the mouse administration conversion factor of 9.1, the composition obtained in the example 1 is dissolved and diluted, the liquid medicines of the low, medium and high dose groups are respectively 83.3mg/ml,166.7mg/ml and 333.3mg/ml, and the mice are gavaged according to the body weight of 0.3ml/20 g; after 30min, the mice are administrated to 56-degree Hongxing Erguotou intragastric mice according to the drinking dose measurement of the mice and the weight of 0.3ml/20 g. The low dose group, the medium dose group and the high dose group were designated, respectively.
30 mice were randomly assigned, 5 per group. After fasting for 12h without water prohibition, the stomach-irrigation administration and drinking are carried out according to the method. After 8h of intragastric administration and drinking, blood and liver were sacrificed for testing. The liver was weighed, homogenized in 10-fold 0.9% physiological saline, centrifuged at 10000rpm, and the supernatant was used to determine the activity of ADH and ALDH enzymes. Standing whole blood at room temperature for 1 hr, centrifuging at low temperature 3000rpm for 20min, collecting serum, and measuring ALT and AST enzyme activities in serum.
TABLE 2 measurement results of mouse liver ADH, ALDH enzyme activity, ALT-clearing enzyme activity and AST enzyme activity (n = 5)
| Group of | ADH(U/mgprot) | ALDH(U/mgprot) | AST(U/L) | ALT(U/L) |
| Blank group | 2.54±0.24 | 7.45±0.62 | 42.78±1.92 | 7.43±0.61 |
| Model set | 3.25±0.22## | 8.01±0.88 | 64.12±4.53## | 12.77±2.17# |
| Positive group | 2.91±0.26 | 7.82±2.4 | 52.4±6.21* | 11.46±2 |
| Low dose | 4.06±0.45* | 7.85±1.83 | 50.96±3.83* | 10.45±0.44 |
| Middle dose | 4.64±0.24** | 8.06±0.76 | 50.01±7.23* | 10.98±2.23 |
| High dose | 5.52±0.57** | 8.18±1.39 | 46.2±2.29*** | 8.67±0.47* |
Compared with the blank group, # P < 0.05, # P < 0.01; compared to the model group: * P < 0.05, P < 0.01, P < 0.001
As can be seen from Table 2 and FIG. 1, the level of Alcohol Dehydrogenase (ADH) activity in the liver of mice after drinking alcohol increased significantly (P < 0.01), and the composition increased the level of Alcohol Dehydrogenase (ADH) activity significantly compared to the model group, and increased the gradient with the increase of the dosage. Acetaldehyde dehydrogenase (ALDH) activity level did not change significantly in all groups, and ALDH activity was higher than ADH activity, and accumulation of acetaldehyde, an intermediate product of alcohol metabolism, did not occur. Experiments show that the composition can obviously improve the alcohol metabolism level after drinking, and is beneficial to sobering up.
After drinking, the level of aspartate Aminotransferase (AST) in the serum of a mouse is obviously increased (P is less than 0.01), compared with a model group, the AST level is obviously reduced by the composition, the effect is improved along with the administration dosage, and the effect is most obvious in a high-dosage group (P is less than 0.001). The level of glutamic-pyruvic transaminase (ALT) is obviously increased (P is less than 0.05) after drinking, and compared with a model group, the level of ALT in a high dose is obviously reduced (P is less than 0.05).
In serum transaminase indexes, alanine Aminotransferase (ALT) is very sensitive under liver injury, and the ALT level is doubled after every 1% of hepatic cell injury; in alcoholic liver injury, the rise of aspartate Aminotransferase (AST) is obvious, and the rise of alanine Aminotransferase (ALT) is not obvious or unchanged. In the experiment, AST is obviously increased after drinking wine, and ALT is not changed greatly (less than 1 time), which indicates that alcohol causes certain damage to the liver after drinking wine by the model group of mice; after the composition is taken, the AST level is obviously reduced, which shows that the composition has obvious inhibiting effect on alcoholic liver injury and has protective effect on liver.
The above detailed description is specific to possible embodiments of the present invention, and the embodiments are not intended to limit the scope of the present invention, and all equivalent implementations or modifications that do not depart from the scope of the present invention are intended to be included within the scope of the present invention.
Claims (10)
1. A traditional Chinese medicine composition with an anti-alcohol function is characterized by comprising the following components: kudzu root, reed rhizome, mulberry leaf, chrysanthemum, lophatherum gracile, lily, polygonatum, chinese yam, raw gardenia and mint.
2. The traditional Chinese medicine composition with the hangover alleviating function according to claim 1, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-30 parts of kudzuvine root, 10-30 parts of reed rhizome, 5-10 parts of mulberry leaf, 5-15 parts of chrysanthemum, 5-10 parts of lophatherum gracile, 10-30 parts of lily, 10-30 parts of fragrant solomonseal rhizome, 15-40 parts of Chinese yam, 5-15 parts of raw gardenia and 5-15 parts of mint.
3. The traditional Chinese medicine composition with the hangover alleviating function according to claim 1, which is prepared from the following raw materials in parts by weight: 20 parts of kudzu root, 20 parts of reed rhizome, 8 parts of mulberry leaf, 10 parts of chrysanthemum, 8 parts of lophatherum gracile, 8 parts of lily, 20 parts of polygonatum, 25 parts of Chinese yam, 10 parts of raw gardenia and 10 parts of mint.
4. The traditional Chinese medicine composition with the hangover alleviating function according to claim 1, further comprising pharmaceutically or food acceptable excipients or additives.
5. The traditional Chinese medicine composition with an anti-alcohol function according to claim 4, wherein the auxiliary materials or additives are one or more of erythritol, sorbitol, microcrystalline cellulose, strawberry fruit powder, maltodextrin, stevioside, magnesium stearate and starch.
6. The preparation method of the traditional Chinese medicine composition with the hangover alleviating function according to any one of claims 1 to 5, wherein the preparation method comprises the following steps:
step one, weighing a certain proportion of kudzu root, reed rhizome, mulberry leaf, chrysanthemum, lophatherum gracile, lily, polygonatum, chinese yam, raw gardenia and mint, and crushing and sieving;
step two, uniformly mixing the sieved raw materials with sorbitol to obtain raw material mixed powder;
step three, carrying out wet granulation on the raw material mixed powder by using alcohol and drying;
step four, mixing the dried granules with magnesium stearate and uniformly stirring to obtain target mixed powder;
and step five, carrying out dosage form treatment on the target mixed powder to obtain the traditional Chinese medicine composition of the target dosage form.
7. The preparation method of the Chinese medicinal composition with the hangover alleviating function according to claim 6, wherein the drying temperature in the third step is 60 ℃, the drying time is 60min, and the moisture content in the dried granules is below 5%.
8. The method for preparing a Chinese medicinal composition with an anti-hangover effect according to claim 6, wherein after the raw materials are weighed in a certain proportion in the first step, the method further comprises: crushing and sieving the raw materials, adding a solvent with the volume 8-10 times of that of the raw materials, extracting, concentrating under reduced pressure, drying, and performing secondary crushing and sieving treatment.
9. The method for preparing a Chinese medicinal composition with anti-hangover effect as claimed in claim 8, wherein the solvent is one of water, ethanol or a mixture of water and ethanol.
10. The method for preparing a Chinese medicinal composition with an anti-hangover effect according to claim 6, wherein the Chinese medicinal composition is in the form of one of pressed candy, tablet, hard capsule, soft capsule, granule, paste, tincture, and oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210865332.0A CN115154556A (en) | 2022-07-21 | 2022-07-21 | A Chinese medicinal composition with anti-hangover effect, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210865332.0A CN115154556A (en) | 2022-07-21 | 2022-07-21 | A Chinese medicinal composition with anti-hangover effect, and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115154556A true CN115154556A (en) | 2022-10-11 |
Family
ID=83497468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210865332.0A Pending CN115154556A (en) | 2022-07-21 | 2022-07-21 | A Chinese medicinal composition with anti-hangover effect, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115154556A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050148A (en) * | 2017-06-13 | 2017-08-18 | 广州中天康顺生物医药有限公司 | A kind of Chinese medicinal composition for dispelling drunk and protecting liver and its preparation method and preparation method thereof |
| CN107596241A (en) * | 2017-09-29 | 2018-01-19 | 黑龙江中医药大学 | A kind of anti-alcohol and liver-protection traditional Chinese medicine composition and its production and use |
| CN107684070A (en) * | 2016-08-04 | 2018-02-13 | 江苏康缘药业股份有限公司 | A kind of sobering-up composition and preparation method thereof and alcohol-decomposing beverage |
| CN108653664A (en) * | 2017-03-30 | 2018-10-16 | 台湾德瑞特生物科技股份有限公司 | Composition of relieving alcoholism and protecting liver and preparation method thereof |
-
2022
- 2022-07-21 CN CN202210865332.0A patent/CN115154556A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107684070A (en) * | 2016-08-04 | 2018-02-13 | 江苏康缘药业股份有限公司 | A kind of sobering-up composition and preparation method thereof and alcohol-decomposing beverage |
| CN108653664A (en) * | 2017-03-30 | 2018-10-16 | 台湾德瑞特生物科技股份有限公司 | Composition of relieving alcoholism and protecting liver and preparation method thereof |
| CN107050148A (en) * | 2017-06-13 | 2017-08-18 | 广州中天康顺生物医药有限公司 | A kind of Chinese medicinal composition for dispelling drunk and protecting liver and its preparation method and preparation method thereof |
| CN107596241A (en) * | 2017-09-29 | 2018-01-19 | 黑龙江中医药大学 | A kind of anti-alcohol and liver-protection traditional Chinese medicine composition and its production and use |
Non-Patent Citations (1)
| Title |
|---|
| 吴晓冰等: "《解酒醒酒与护肝养胃》" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9968644B2 (en) | Traditional chinese medicine composition for sober-up and hepatic protection and a process for preparing the same | |
| CN106975069B (en) | Liver-protecting composition and preparation method thereof | |
| CN103055274A (en) | Chinese medicinal composition for dispelling drunk and protecting liver and its preparation method | |
| CN106135891A (en) | A kind of health food to alcoholic liver injury with defencive function | |
| US10111451B2 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
| CN107233442B (en) | Composition capable of improving gout discomfort symptoms and fingerprint spectrum establishment method | |
| CN113995788B (en) | Liver protection composition and preparation process thereof | |
| CN101244110A (en) | Chinese medicine composition with function of releasing fatigue, reinforcing immunity, and preparation method | |
| CN114028533A (en) | Composition with functions of dispelling effects of alcohol and protecting liver and preparation method and application thereof | |
| CN112690450A (en) | Composition for relieving alcoholism and protecting liver, preparation method thereof and product containing composition | |
| CN112618608A (en) | Composition with function of dispelling effects of alcohol and preparation method and application thereof | |
| CN111632081A (en) | Compound blueberry hovenia acerba tablet with effects of dispelling effects of alcohol and protecting liver and preparation method thereof | |
| CN111870627A (en) | Sobering-up preparation and its preparing method and use | |
| WO2005094858A1 (en) | Antidiabetic composition | |
| CN115154556A (en) | A Chinese medicinal composition with anti-hangover effect, and its preparation method | |
| CN104622993B (en) | Chewable tablet with protective effect on alcoholic liver injuries and preparation method of chewable tablet | |
| WO2014134833A1 (en) | Edible composition, preparation method therefor, and food product comprising the composition | |
| CN104585469B (en) | A kind of chewing gum to alcoholic liver injury with protective effect and preparation method thereof | |
| CN112691150A (en) | Composition and preparation method and application thereof | |
| CN110881657A (en) | Composition with function of dispelling effects of alcohol and preparation method and application thereof | |
| KR101154031B1 (en) | Composition for Antifati gue containin g herbal mixture extract as in gredient compounds | |
| CN104666931A (en) | Composition with effects of protecting liver and dispelling effects of alcohol and application of composition | |
| CN106387915B (en) | Qi and coffee vigor-benefiting effervescent tablet and preparation process and application thereof | |
| CN112057476B (en) | Composition and application thereof in sobering-up, hangover-relieving and stomach-protecting | |
| CN112494626B (en) | Tablet with protective effect on chemical liver injury and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221011 |